Advocacy intelligence hub — real-time data for patient organizations
GlaxoSmithKline — PHASE1
Institute of Liver and Biliary Sciences, India — NA
The Affiliated Hospital of Hangzhou Normal University — NA
Dong Hui — PHASE2
Steno Diabetes Center Copenhagen — NA
Rigshospitalet, Denmark — NA
Zhujiang Hospital — PHASE4
Charite University, Berlin, Germany — NA
Western University, Canada — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all NON RARE IN EUROPE: Non-alcoholic fatty liver disease news →
View all NON RARE IN EUROPE: Non-alcoholic fatty liver disease specialists →